Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients

Obesity

Volumn 19, Issue 11, 2011, Pages 2235-2240

  Huang, Hazel ^a   Kasumov, Takhar ^a   Gatmaitan, Patrick ^b   Heneghan, Helen M ^a   Kashyap, Sangeeta R ^a   Schauer, Philip R ^a   Brethauer, Stacy A ^a   Kirwan, John P ^a,c  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CHI Valley Surgeons   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; CHOLESTEROL; FATTY ACID; HIGH DENSITY LIPOPROTEIN; INSULIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DISEASE SEVERITY; ELECTROSPRAY MASS SPECTROMETRY; FATTY ACID BLOOD LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INSULIN SENSITIVITY; LAPAROSCOPIC SURGERY; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; OBESITY; PLASMA CERAMIDE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; ROUX Y ANASTOMOSIS; STOMACH BYPASS; TANDEM MASS SPECTROMETRY; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CERAMIDES; FATTY ACIDS; FEMALE; FOLLOW-UP STUDIES; GASTRIC BYPASS; HUMANS; INSULIN RESISTANCE; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; OBESITY; POSTOPERATIVE CARE; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA; WEIGHT LOSS;

EID: 80055030207     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.107     Document Type: Article

References (41)

1. Hill JO, Wyatt HR, Reed GW, Peters JC. Obesity and the environment: where do we go from here? Science 2003;299:853-855. (Pubitemid 36182434)
2. Samuel VT, Petersen KF, Shulman GI. Lipid-induced insulin resistance: unravelling the mechanism. Lancet 2010;375:2267-2277.
3. Tretjakovs P, Jurka A, Bormane I et al. Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients. Eur J Intern Med 2009;20:712-717.
4. Vázquez LA, Pazos F, Berrazueta JR et al. Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 2005;90: 316-322. (Pubitemid 40116674)
5. Summers SA. Ceramides in insulin resistance and lipotoxicity. Prog Lipid Res 2006;45:42-72. (Pubitemid 43170804)
6. Holland WL, Brozinick JT, Wang LP et al. Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 2007;5:167-179.
7. Jiang XC, Paultre F, Pearson TA et al. Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol 2000;20:2614-2618.
8. Haus JM, Kashyap SR, Kasumov T et al. Plasma ceramides are elevated in obese subjects with type 2 diabetes and correlate with the severity of insulin resistance. Diabetes 2009;58:337-343.
9. Augé N, Maupas-Schwalm F, Elbaz M et al. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation. Circulation 2004;110:571-578. (Pubitemid 39031175)
10. Augé N, Nègre-Salvayre A, Salvayre R, Levade T. Sphingomyelin metabolites in vascular cell signaling and atherogenesis. Prog Lipid Res 2000;39: 207-229. (Pubitemid 30224704)
11. Hojjati MR, Li Z, Zhou H et al. Effect of myriocin on plasma sphingolipid metabolism and atherosclerosis in apoE-deficient mice. J Biol Chem 2005;280:10284-10289. (Pubitemid 40395884)
12. Li H, Junk P, Huwiler A et al. Dual effect of ceramide on human endothelial cells: induction of oxidative stress and transcriptional upregulation of endothelial nitric oxide synthase. Circulation 2002;106:2250-2256. (Pubitemid 35222221)
13. Shimabukuro M, Zhou YT, Levi M, Unger RH. Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci USA 1998;95:2498-2502. (Pubitemid 28145970)
14. Summers SA, Nelson DH. A role for sphingolipids in producing the common features of type 2 diabetes, metabolic syndrome X, and Cushing's syndrome. Diabetes 2005;54:591-602. (Pubitemid 40322059)
15. Samad F, Loskutoff DJ. Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol Med 1996;2:568-582. (Pubitemid 26353106)
16. Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci USA 2003;100:7265-7270. (Pubitemid 36706427)
17. Weisberg SP, Hunter D, Huber R et al. CCR2 modulates inflammatory and metabolic effects of high-fat feeding. J Clin Invest 2006;116:115-124. (Pubitemid 43121796)
18. Weisberg SP, McCann D, Desai M et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112: 1796-1808. (Pubitemid 38063703)
19. Kirwan JP, Hauguel-De Mouzon S, Lepercq J et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002;51:2207-2213. (Pubitemid 34729026)
20. Kirwan JP, del Aguila LF, Hernandez JM et al. Regular exercise enhances insulin activation of IRS-1-associated PI3-kinase in human skeletal muscle. J Appl Physiol 2000;88:797-803. (Pubitemid 30097130)
21. Adams JM 2nd, Pratipanawatr T, Berria R et al. Ceramide content is increased in skeletal muscle from obese insulin-resistant humans. Diabetes 2004;53:25-31. (Pubitemid 38044694)
22. Pories WJ, Swanson MS, MacDonald KG et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995;222:339-350; discussion 350.
23. Schauer PR, Burguera B, Ikramuddin S et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467-484; discussion 484.
24. Habib P, Scrocco JD, Terek M, Vanek V, Mikolich JR. Effects of bariatric surgery on inflammatory, functional and structural markers of coronary atherosclerosis. Am J Cardiol 2009;104:1251-1255.
25. Batsis JA, Romero-Corral A, Collazo-Clavell ML et al. Effect of bariatric surgery on the metabolic syndrome: a population-based, long-term controlled study. Mayo Clin Proc 2008;83:897-907.
26. Kashyap SR, Daud S, Kelly KR et al. Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes. Int J Obes (Lond) 2010;34:462-471.
27. NIH Conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med 1991;115:956-961.
28. Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410. (Pubitemid 32269192)
29. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959;37:911-917.
30. Kasumov T, Huang H, Chung YM et al. Quantification of ceramide species in biological samples by liquid chromatography electrospray ionization tandem mass spectrometry. Anal Biochem 2010;401:154-161.
31. Ichi I, Nakahara K, Miyashita Y et al. Association of ceramides in human plasma with risk factors of atherosclerosis. Lipids 2006;41:859-863. (Pubitemid 44788907)
32. Samad F, Hester KD, Yang G, Hannun YA, Bielawski J. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk. Diabetes 2006;55:2579-2587. (Pubitemid 44871159)
33. Jones KB Jr. The Effect of Gastric Bypass on Cholesterol, HDL, and the Risk of Coronary Heart Disease. Obes Surg 1992;2:83-85.
34. Gatmaitan P, Huang H, Talarico J et al. Pancreatic islet isolation after gastric bypass in a rat model: technique and initial results for a promising research tool. Surg Obes Relat Dis 2010;6:532-537.
35. Holland WL, Summers SA. Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism. Endocr Rev 2008;29:381-402. (Pubitemid 351831506)
36. Schmitz-Peiffer C, Craig DL, Biden TJ. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J Biol Chem 1999;274:24202-24210.
37. Hajduch E, Balendran A, Batty IH et al. Ceramide impairs the insulindependent membrane recruitment of protein kinase B leading to a loss in downstream signalling in L6 skeletal muscle cells. Diabetologia 2001;44:173-183. (Pubitemid 32156201)
38. Lightle SA, Oakley JI, Nikolova-Karakashian MN. Activation of sphingolipid turnover and chronic generation of ceramide and sphingosine in liver during aging. Mech Ageing Dev 2000;120:111-125.
39. Schissel SL, Schuchman EH, Williams KJ, Tabas I. Zn2+-stimulated sphingomyelinase is secreted by many cell types and is a product of the acid sphingomyelinase gene. J Biol Chem 1996;271:18431-18436. (Pubitemid 26322699)
40. Wong ML, Xie B, Beatini N et al. Acute systemic inflammation up-regulates secretory sphingomyelinase in vivo: a possible link between inflammatory cytokines and atherogenesis. Proc Natl Acad Sci USA 2000;97:8681-8686. (Pubitemid 30639733)
41. Jenkins RW, Canals D, Idkowiak-Baldys J et al. Regulated secretion of acid sphingomyelinase: implications for selectivity of ceramide formation. J Biol Chem 2010;285:35706-35718